Skip to main content
Caplight Logo









Octocells

Octocells

Private
RouenHealthcare & Life Scienceshttps://www.octocells.com/

Last Round

Accelerator

Jan 31, 2025

Company Overview

Octocells is a biotechnology company that develops animal-free, three-dimensional cell culture technologies designed to enable scalable and reproducible cell growth for research and bioproduction.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Advanced Materials

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Government Contracts

AI Layer

Application

Keywords

3D cell cultureanimal-free bioscaffoldbioscaffoldingbioproductioncellular agriculturecultivated meatcell therapyscalable cell culturelab consumablespreclinical screeningdrug discoveryhyaluronic acid bioscaffoldlab-grown meatdigital twin

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Octocells Comparables

Compare Octocells with similar companies based on industry and business-model similarity.

Octocells comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
TheWell Bioscience
83%
Manchester BIOGEL
78%
denovoMATRIX
78%

Octocells Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorJan 31, 2025

Key People

Founding team and executive leadership

Grégory MAUBON

CTO And Cofounder

Founding Team

Zied Souguir

CEO

Executive Team

Octocells Investors

Notable investors and investment history

Octocells investors
InvestorRounds
3DEXPERIENCE LabAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 31, 2025

    Received funding from 3DEXPERIENCE Lab.

Octocells Filings

Explore SEC and related filing metadata, where available.

Octocells filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Octocells's valuation, stock price, and market status.

Is Octocells a public or private company?

Octocells is a private company.

What is the current stock price of Octocells?

Octocells is a private company with no public stock price. No recent secondary market data is available.

How much is Octocells worth (valuation)?

Valuation information for Octocells is not publicly available.

Can I buy Octocells stock?

Octocells shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Octocells's last funding round?

Octocells's most recent funding round was Accelerator on January 31, 2025.

Who are the main investors in Octocells?

Key investors in Octocells include 3DEXPERIENCE Lab.

Will Octocells IPO soon?

No public IPO plans have been announced for Octocells.

How can I track Octocells secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Octocells's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersRouen
Employee Range3
Year Founded2022
Last FundingJan 31, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?